搜索医生

Rohit D. Divekar, M.B.B.S., Ph.D.

  1. Allergist-Immunologist
  2. Internist
预约门诊

出版物

  1. O'Brien EK, Jerschow E, Divekar RD. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold? Otolaryngol Clin North Am. 2024 Apr; 57 (2):265-278 Epub 2023 Oct 11
    View PubMed
  2. Dages KN, Sofola-James O, Sehanobish E, Regula P, Chen CC, Chiarella SE, Divekar RD, Cohen HW, Jerschow E. Sex, Ethnicity, Body Mass Index, and Environmental Exposures Associated With NSAID-Exacerbated Respiratory Disease Symptom Sequence. J Allergy Clin Immunol Pract. 2023 Dec; 11 (12):3662-3669.e2 Epub 2023 Aug 02
    View PubMed
  3. Lau S, Sprung J, Volcheck GW, Butterfield JH, Divekar RD, Weingarten TN. Perioperative management of mastocytosis. J Anesth. 2023 Oct; 37 (5):741-748 Epub 2023 July 19
    View PubMed
  4. Pongdee T, Larson NB, Divekar R, Bielinski SJ, Liu H, Moon S. Automated Identification of Aspirin-Exacerbated Respiratory Disease Using Natural Language Processing and Machine Learning: Algorithm Development and Evaluation Study. JMIR AI. 2023 Jun 12; 2:e44191 Epub 2023 June 12
    View PubMed
  5. D'Netto M, Sofola-James O, Sehanobish E, Divekar R, Jerschow E. During aspirin desensitization, omitting repeated provoking aspirin dose is safe. J Allergy Clin Immunol Pract. 2023 Mar; 11 (3):955-957 Epub 2022 Dec 16
    View PubMed
  6. Walters BK, Hagan JB, Divekar RD, Willson TJ, Stokken JK, Pinheiro-Neto CD, O'Brien EK, Choby G. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review. Otolaryngol Clin North Am. 2023 Feb; 56(1):107-124. Epub 2022 Oct 22.
    View PubMed
  7. Miglani A, Lal D, Divekar RD. Unified Airway Disease: Diagnosis and Subtyping. Otolaryngol Clin North Am. 2023 Feb; 56 (1):11-22
    View PubMed
  8. Mandke C, Divekar R, Pradhan V, Arora S. Quantitative B and T cell abnormalities in four patients presenting with mucormycosis and prior asymptomatic COVID-19 infection. BMJ Case Rep. 2022 Aug 9; 15 (8) Epub 2022 Aug 09
    View PubMed
  9. Hagan JB, Ender E, Divekar RD, Pongdee T, Rank MA. Risk for Postmarket Black Box Warnings in FDA-Approved Monoclonal Antibodies. Mayo Clin Proc Innov Qual Outcomes. 2022 Feb; 6(1):69-76. Epub 2021 Dec 28.
    View PubMed
  10. Choby G, Low CM, Levy JM, Stokken JK, Pinheiro-Neto C, Bartemes K, Marino M, Han JK, Divekar R, O'Brien EK, Lal D. Urine Leukotriene E4: Implications as a Biomarker in Chronic Rhinosinusitis. Otolaryngol Head Neck Surg. 2022 Feb; 166(2):224-232. Epub 2021 May 11.
    View PubMed
  11. Seol HY, Wi CI, Ryu E, King KS, Divekar RD, Juhn YJ. A diagnostic codes-based algorithm improves accuracy for identification of childhood asthma in archival data sets. J Asthma. 2021 Aug; 58 (8):1077-1086 Epub 2020 May 20
    View PubMed
  12. Sitek AN, Ade JM, Chiarella SE, Divekar RD, Pitlick MM, Iyer VN, Wang Z, Joshi AY. Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis. Allergy Asthma Proc. 2021 Jul 1; 42 (4):267-273
    View PubMed
  13. Pitlick MM, Divekar R. Analysis of spirometry measurements as predictors of aspirin desensitization outcomes. J Allergy Clin Immunol Pract. 2021 Jun; 9 (6):2495-2497.e2 Epub 2021 Feb 02
    View PubMed
  14. Choby G, O'Brien EK, Smith A, Barnes J, Hagan J, Stokken JK, Strumpf A, Mattos JL, Payne SC, Divekar R. Elevated Urine Leukotriene E4 Is Associated With Worse Objective Markers in Nasal Polyposis Patients. Laryngoscope. 2021 May; 131 (5):961-966 Epub 2020 Oct 01
    View PubMed
  15. Bhavnani SK, Dang B, Penton R, Visweswaran S, Bassler KE, Chen T, Raji M, Divekar R, Zuhour R, Karmarkar A, Kuo YF, Ottenbacher KJ. How High-Risk Comorbidities Co-Occur in Readmitted Patients With Hip Fracture: Big Data Visual Analytical Approach. JMIR Med Inform. 2020 Oct 26; 8 (10):e13567
    View PubMed
  16. Neth BJ, Ruff MW, Uhm JH, Johnson DR, Divekar RD, Maddox DE. Temozolomide desensitization followed by metronomic dosing in patients with hypersensitivity. Cancer Chemother Pharmacol. 2020 Sep; 86 (3):375-382 Epub 2020 Aug 10
    View PubMed
  17. Sheen YH, Kizilbash S, Ryoo E, Wi CI, Park M, Abraham RS, Ryu E, Divekar R, Juhn Y. Relationship between asthma status and antibody response pattern to 23-valent pneumococcal vaccination. J Asthma. 2020 Apr; 57 (4):381-390 Epub 2019 Feb 20
    View PubMed
  18. Nanda A, Baptist AP, Divekar R, Parikh N, Seggev JS, Yusin JS, Nyenhuis SM. Asthma in the older adult. J Asthma. 2020 Mar; 57 (3):241-252 Epub 2019 Jan 18
    View PubMed
  19. Lal D, Wright BL, Shim KP, Zarka MA, Lee JJ, Chang YH, Ochkur SI, Divekar R, Doyle AD, Jacobsen EA, Kita H, Rank MA. Eosinophil peroxidase, GATA3, and T-bet as tissue biomarkers in chronic rhinosinusitis. J Allergy Clin Immunol 2019 Jun; 143 (6):2284-2287.e6 Epub 2019 Feb 08
    View PubMed
  20. Bhavnani SK, Visweswaran S, Divekar R, Brasier AR. Towards team-centered informatics: Accelerating innovation in multidisciplinary scientific teams through visual analytics Journal of Applied Behavioral Science. 2019 Mar; 55 (1):50-72
  21. Miglani A, Divekar RD, Azar A, Rank MA, Lal D. Revision endoscopic sinus surgery rates by chronic rhinosinusitis subtype. Int Forum Allergy Rhinol. 2018 Sep; 8 (9):1047-1051 Epub 2018 May 31
    View PubMed
  22. Lal D, Hopkins C, Divekar RD. SNOT-22-based clusters in chronic rhinosinusitis without nasal polyposis exhibit distinct endotypic and prognostic differences. Int Forum Allergy Rhinol. 2018 Jul; 8 (7):797-805 Epub 2018 Feb 13
    View PubMed
  23. Divekar R, Lal D. Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis. F1000Res. 2018; 7:412 Epub 2018 Mar 29
    View PubMed
  24. Patel B, Wi CI, Hasassri ME, Divekar R, Absah I, Almallouhi E, Ryu E, King K, Juhn YJ. Heterogeneity of asthma and the risk of celiac disease in children. Allergy Asthma Proc. 2018 Jan 1; 39 (1):51-58
    View PubMed
  25. Hagan JB, Laidlaw TM, Divekar R, O'Brien EK, Kita H, Volcheck GW, Hagan CR, Lal D, Teaford HG 3rd, Erwin PJ, Zhang N, Rank MA. Urinary Leukotriene E4 to Determine Aspirin Intolerance in Asthma: A Systematic Review and Meta-Analysis. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5 (4):990-997.e1 Epub 2017 Feb 12
    View PubMed
  26. Hartono S, Motosue MS, Khan S, Rodriguez V, Iyer VN, Divekar R, Joshi AY. Predictors of granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency. Ann Allergy Asthma Immunol. 2017 May; 118 (5):614-620 Epub 2017 Feb 20
    View PubMed
  27. Divekar R, Rank M, Squillace D, Kita H, Lal D. Unsupervised network mapping of commercially available immunoassay yields three distinct chronic rhinosinusitis endotypes. Int Forum Allergy Rhinol. 2017 Apr; 7 (4):373-379 Epub 2017 Jan 02
    View PubMed
  28. Patel B, Divekar R. Urinary N-methyl histamine levels relate to the presence of angioedema and decrease with the duration of chronic urticaria. J Allergy Clin Immunol Pract 2017 Jan - Feb; 5 (1):201-203 Epub 2016 Nov 09
    View PubMed
  29. Lal D, Golisch KB, Elwell ZA, Divekar RD, Rank MA, Chang YH. Gender-specific analysis of outcomes from endoscopic sinus surgery for chronic rhinosinusitis. Int Forum Allergy Rhinol. 2016 Sep; 6 (9):896-905 Epub 2016 Apr 15
    View PubMed
  30. Divekar R, Hagan J, Rank M, Park M, Volcheck G, O'Brien E, Meeusen J, Kita H, Butterfield J. Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin Sensitivity. J Allergy Clin Immunol Pract. 2016 Jul-Aug; 4 (4):665-70 Epub 2016 Apr 12
    View PubMed
  31. Willits E, Divekar R. Dupilumab Therapy in Patients with Nasal Polyposis and Chronic Sinusitis. J Allergy Clin Immunol Pract. 2016 Jul-Aug; 4 (4):786-787 Epub 2016 May 13
    View PubMed
  32. Divekar R, Butterfield J, Maddox D. Successful rapid desensitization to temozolomide: A case series. J Allergy Clin Immunol Pract 2016 May-Jun; 4 (3):545-6 Epub 2016 Jan 20
    View PubMed
  33. Lal D, Rounds AB, Divekar R. Gender-specific differences in chronic rhinosinusitis patients electing endoscopic sinus surgery. Int Forum Allergy Rhinol. 2016 Mar; 6: (3)278-86.
    View PubMed
  34. Divekar R, Patel N, Jin J, Hagan J, Rank M, Lal D, Kita H, O'Brien E. Symptom-Based Clustering in Chronic Rhinosinusitis Relates to History of Aspirin Sensitivity and Postsurgical Outcomes. J Allergy Clin Immunol Pract. 2015 Nov-Dec; 3 (6):934-40.e3 Epub 2015 July 26
    View PubMed
  35. Divekar R, Butterfield J, Butterfield J. Urinary 11beta-PGF2alpha and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders. Allergy. 2015 Oct; 70 (10):1230-8 Epub 2015 June 24
    View PubMed
  36. Pyle RC, Divekar R, May SM, Narla N, Pianosi PT, Hartz MF, Ott NL, Park MA, McWilliams DB, Green JA, Despins KN, Joshi AY. Asthma-associated comorbidities in children with and without secondhand smoke exposure. Ann Allergy Asthma Immunol. 2015 Sep; 115: (3)205-10.
    View PubMed
  37. Lal D, Rounds AB, Rank MA, Divekar R. Clinical and 22-item Sino-Nasal Outcome Test symptom patterns in primary headache disorder patients presenting to otolaryngologists with "sinus" headaches, pain or pressure. Int Forum Allergy Rhinol. 2015 May; 5: (5)408-16.
    View PubMed
  38. Bhavnani SK, Dang B, Bellala G, Divekar R, Visweswaran S, Brasier AR, Kurosky A. Unlocking proteomic heterogeneity in complex diseases through visual analytics. Proteomics. 2015 Apr; 15(8):1405-18.
    View PubMed
  39. Divekar RD, Samant S, Rank MA, Hagan J, Lal D, O'Brien EK, Kita H. Immunological profiling in chronic rhinosinusitis with nasal polyps reveals distinct VEGF and GM-CSF signatures during symptomatic exacerbations. Clin Exp Allergy. 2015 Apr; 45 (4):767-78
    View PubMed
  40. Divekar R, Kita H. Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation. Curr Opin Allergy Clin Immunol. 2015 Feb; 15 (1):98-103
    View PubMed
  41. Sprung J, Larson KJ, Divekar RD, Butterfield JH, Schwartz LB, Weingarten TN. Refractory intraoperative hypotension with elevated serum tryptase. Asia Pac Allergy. 2015 Jan; 5 (1):47-50 Epub 2015 Jan 28
    View PubMed
  42. Bhavnani SK, Dang B, Visweswaran S, Divekar R, Tan A, Karmarkar A, Ottenbacher K. How Comorbidities Co-Occur in Readmitted Hip Fracture Patients: From Bipartite Networks to Insights for Post-Discharge Planning. AMIA Jt Summits Transl Sci Proc. 2015; 2015:36-40 Epub 2015 Mar 25
    View PubMed
  43. Bhavnani SK, Dang B, Caro M, Bellala G, Visweswaran S, Mejias A, Divekar R. Heterogeneity within and across Pediatric Pulmonary Infections: From Bipartite Networks to At-Risk Subphenotypes. AMIA Jt Summits Transl Sci Proc. 2014; 2014:29-34 Epub 2014 Apr 07
    View PubMed
  44. Divekar R, Ameredes BT, Calhoun WJ. Symptom-based controller therapy: a new paradigm for asthma management. Curr Allergy Asthma Rep. 2013 Oct; 13(5):427-33.
    View PubMed
  45. Cascio JA, Haymaker CL, Divekar RD, Zaghouani S, Khairallah MT, Wan X, Rowland LM, Dhakal M, Chen W, Zaghouani H. Antigen-specific effector CD4 T lymphocytes school lamina propria dendritic cells to transfer innate tolerance. J Immunol. 2013 Jun 15; 190(12):6004-14. Epub 2013 May 17.
    View PubMed
  46. Pillai RR, Divekar R, Brasier A, Bhavnani S, Calhoun WJ. Strategies for molecular classification of asthma using bipartite network analysis of cytokine expression. Curr Allergy Asthma Rep. 2012 Oct; 12(5):388-95.
    View PubMed
  47. Divekar RD, Haymaker CL, Cascio JA, Guloglu BF, Ellis JS, Tartar DM, Hoeman CM, Franklin CL, Zinselmeyer BH, Lynch JN, Miller MJ, Zaghouani H. T cell dynamics during induction of tolerance and suppression of experimental allergic encephalomyelitis. J Immunol. 2011 Oct 15; 187(8):3979-86. Epub 2011 Sep 12.
    View PubMed
  48. Zhang J, Lee SM, Shannon S, Gao B, Chen W, Chen A, Divekar R, McBurney MW, Braley-Mullen H, Zaghouani H, Fang D. The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice. J Clin Invest. 2009 Oct; 119(10):3048-58.
    View PubMed
  49. Divekar RD, Mehta P. Hepatocellular carcinoma: the facts of the matter. Federal Practitioner. 2009 May.
  50. Lee HH, Hoeman CM, Hardaway JC, Guloglu FB, Ellis JS, Jain R, Divekar R, Tartar DM, Haymaker CL, Zaghouani H. Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. J Exp Med. 2008 Sep 29; 205(10):2269-80. Epub 2008 Sep 01.
    View PubMed
  51. Yu P, Haymaker CL, Divekar RD, Ellis JS, Hardaway J, Jain R, Tartar DM, Hoeman CM, Cascio JA, Ostermeier A, Zaghouani H. Fetal exposure to high-avidity TCR ligand enhances expansion of peripheral T regulatory cells. J Immunol. 2008 Jul 1; 181(1):73-80.
    View PubMed
  52. Bell JJ, Divekar RD, Ellis JS, Cascio JA, Haymaker CL, Jain R, Tartar DM, Hoeman CM, Hardaway JC, Zaghouani H. In trans T cell tolerance diminishes autoantibody responses and exacerbates experimental allergic encephalomyelitis. J Immunol. 2008 Feb 1; 180(3):1508-16.
    View PubMed
  53. Jain R, Tartar DM, Gregg RK, Divekar RD, Bell JJ, Lee HH, Yu P, Ellis JS, Hoeman CM, Franklin CL, Zaghouani H. Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J Exp Med. 2008 Jan 21; 205(1):207-18. Epub 2008 Jan 14.
    View PubMed
  54. Bell JJ, Ellis JS, Guloglu FB, Tartar DM, Lee HH, Divekar RD, Jain R, Yu P, Hoeman CM, Zaghouani H. Early effector T cells producing significant IFN-gamma develop into memory. J Immunol. 2008 Jan 1; 180(1):179-87.
    View PubMed
  55. Yu P, Gregg RK, Bell JJ, Ellis JS, Divekar R, Lee HH, Jain R, Waldner H, Hardaway JC, Collins M, Kuchroo VK, Zaghouani H. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J Immunol. 2005 Jun 1; 174(11):6772-80.
    View PubMed
  56. Gregg RK, Bell JJ, Lee HH, Jain R, Schoenleber SJ, Divekar R, Zaghouani H. IL-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance. J Immunol. 2005 Jan 15; 174(2):662-70.
    View PubMed
  57. Gregg RK, Jain R, Schoenleber SJ, Divekar R, Bell JJ, Lee HH, Yu P, Zaghouani H. A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes. J Immunol. 2004 Dec 15; 173(12):7308-16.
    View PubMed
PST-20227484